Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
Authors
Keywords
Hepatocellular carcinoma, Antiangiogenic treatment, Image biomarker, Dynamic contrast-enhanced MRI, Diffusion-weighted imaging, Circulating biomarker
Journal
Journal of Hematology & Oncology
Volume 6, Issue 1, Pages 51
Publisher
Springer Nature
Online
2013-07-10
DOI
10.1186/1756-8722-6-51
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2013) A. X. Zhu et al. CLINICAL CANCER RESEARCH
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Established and novel imaging biomarkers for assessing response to therapy in hepatocellular carcinoma
- (2012) Tao Jiang et al. JOURNAL OF HEPATOLOGY
- Phase I Dose-Finding Study of Pazopanib in Hepatocellular Carcinoma: Evaluation of Early Efficacy, Pharmacokinetics, and Pharmacodynamics
- (2011) T. Yau et al. CLINICAL CANCER RESEARCH
- Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
- (2011) Chao-Yu Hsu et al. JOURNAL OF HEPATOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
- (2010) A. J. de Langen et al. JOURNAL OF NUCLEAR MEDICINE
- Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
- (2010) Marcus Alexander Wörns et al. ONCOLOGY
- Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization
- (2010) Johnathan C Chung WORLD JOURNAL OF GASTROENTEROLOGY
- Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival
- (2009) W. R. Jarnagin et al. ANNALS OF ONCOLOGY
- Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
- (2009) N Murukesh et al. BRITISH JOURNAL OF CANCER
- Development of Sunitinib in Hepatocellular Carcinoma: Rationale, Early Clinical Experience, and Correlative Studies
- (2009) Andrew X. Zhu et al. CANCER JOURNAL
- Imaging of Hepatocellular Carcinoma by Computed Tomography and Magnetic Resonance Imaging: State of the Art
- (2009) Christoph J. Zech et al. DIGESTIVE DISEASES
- Predicting Control of Primary Tumor and Survival by DCE MRI During Early Therapy in Cervical Cancer
- (2009) William T. C. Yuh et al. INVESTIGATIVE RADIOLOGY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study
- (2009) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study
- (2009) Sandrine Faivre et al. LANCET ONCOLOGY
- Differentiation of Malignant Thrombus from Bland Thrombus of the Portal Vein in Patients with Hepatocellular Carcinoma: Application of Diffusion-weighted MR Imaging
- (2009) Onofrio A. Catalano et al. RADIOLOGY
- Systemic Therapy for Hepatocellular Carcinoma
- (2008) Melanie B. Thomas CANCER JOURNAL
- Imaging techniques to evaluate the response to treatment in oncology: Current standards and perspectives
- (2008) C.D. Marcus et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2008) Abby B. Siegel et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging
- (2008) Daniel P. Barboriak et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started